Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WA › SEATTLE › UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON

NPI: 1710105010 · SEATTLE, WA 98195 · Clinical Medical Laboratory · NPI assigned 04/23/2007

$36.65M
Total Medicaid Paid
1,195,046
Total Claims
1,033,853
Beneficiaries
195
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCOLLANTES, MARCELO (CHIEF FINANCIAL OFFICER LABMED)
NPI Enumeration Date04/23/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 64,662 $1.25M
2019 67,761 $1.38M
2020 148,790 $6.81M
2021 411,732 $15.09M
2022 315,740 $9.11M
2023 106,892 $1.79M
2024 79,469 $1.23M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 428,490 343,187 $26.38M
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 74,832 59,904 $1.32M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 14,531 13,490 $1.23M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 22,436 19,763 $771K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 22,427 19,698 $762K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9,692 9,060 $468K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 15,850 15,554 $319K
84443 Thyroid stimulating hormone (TSH) 22,956 22,084 $300K
80050 General health panel 10,949 10,791 $299K
80061 Lipid panel 32,426 30,913 $299K
80053 Comprehensive metabolic panel 35,296 33,440 $281K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,152 2,980 $205K
87507 604 590 $180K
86235 1,852 1,818 $172K
86480 2,986 2,949 $167K
86780 12,442 12,221 $146K
86803 12,513 12,284 $137K
83013 2,191 2,148 $133K
82728 12,500 12,136 $129K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 19,270 18,153 $123K
82607 9,100 8,764 $112K
84403 4,847 4,707 $104K
86038 8,124 7,962 $90K
85027 16,371 15,700 $86K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 8,111 7,960 $85K
80048 Basic metabolic panel (calcium, ionized) 11,663 10,901 $78K
82746 6,411 6,186 $78K
87086 Culture, bacterial; quantitative colony count, urine 10,552 9,907 $75K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2,886 2,826 $74K
83516 3,647 3,569 $66K
84270 3,376 3,282 $64K
87536 838 811 $62K
87529 985 958 $61K
82274 4,345 4,178 $59K
84466 5,679 5,508 $57K
87522 Neg quan hep c or qual rna 1,447 1,402 $55K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,113 1,084 $54K
82670 2,097 2,054 $53K
83036 Hemoglobin; glycosylated (A1C) 9,586 9,174 $52K
36415 Collection of venous blood by venipuncture 12,092 11,386 $45K
83655 3,828 3,798 $45K
86706 5,277 5,157 $44K
87340 4,831 4,719 $40K
84439 5,104 4,851 $38K
86481 459 446 $35K
83520 1,502 1,454 $34K
82043 6,801 6,418 $32K
86696 1,911 1,887 $31K
82570 7,317 6,903 $30K
87186 3,428 3,283 $29K
83540 5,714 5,541 $29K
86141 2,274 2,227 $29K
82542 1,505 1,460 $28K
84630 2,810 2,730 $26K
84702 2,052 1,855 $26K
83001 1,530 1,506 $26K
82525 2,413 2,314 $25K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 370 360 $23K
86695 1,915 1,890 $23K
87081 3,667 3,618 $23K
86225 2,029 1,981 $22K
84146 1,247 1,220 $22K
84153 1,704 1,593 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 476 471 $22K
86787 1,930 1,896 $21K
87077 2,409 2,289 $21K
86200 1,687 1,657 $20K
87205 4,440 4,325 $18K
84590 1,849 1,803 $18K
82105 1,153 1,083 $18K
86769 611 585 $17K
84446 1,473 1,436 $17K
87631 141 140 $17K
83735 3,031 2,790 $17K
86762 1,255 1,228 $16K
81001 5,696 5,412 $15K
83690 2,405 2,342 $15K
87147 1,877 1,830 $15K
86364 1,373 1,359 $15K
87497 421 313 $14K
87070 1,764 1,721 $14K
80503 3,742 3,284 $14K
87088 1,852 1,775 $14K
80076 1,890 1,835 $14K
86140 3,116 3,003 $14K
83014 2,184 2,144 $13K
86258 1,215 1,199 $13K
83880 454 416 $13K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 1,265 1,211 $13K
85652 5,130 4,988 $13K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 149 149 $12K
80504 1,377 1,262 $12K
86431 1,973 1,935 $10K
86704 1,057 1,035 $10K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 25 25 $10K
83970 286 271 $9K
84165 1,682 837 $9K
87209 489 463 $9K
87806 1,848 1,825 $9K
84163 571 566 $8K
87102 1,064 1,043 $8K
83002 473 465 $8K
80502 384 372 $8K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 65 65 $7K
84481 478 465 $7K
84202 510 508 $7K
80197 621 489 $6K
85610 1,880 1,649 $6K
86765 528 525 $6K
86708 629 607 $6K
87046 769 752 $6K
80500 972 901 $5K
86376 402 393 $5K
84550 1,380 1,310 $5K
84480 354 345 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 84,323 64,401 $5K
83525 411 409 $5K
86160 201 195 $4K
86735 371 366 $4K
87177 507 480 $4K
82248 1,131 1,042 $4K
0097U 347 343 $4K
87338 296 296 $4K
86800 239 234 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 14 13 $3K
86850 384 368 $3K
82677 112 108 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 206 204 $3K
86334 362 177 $3K
92060 39 39 $3K
87593 18 17 $3K
83993 147 143 $3K
83521 110 101 $2K
87799 173 161 $2K
86256 97 96 $2K
87210 414 405 $2K
87252 55 55 $2K
85730 504 490 $2K
86255 145 139 $2K
87999 52 51 $2K
84460 390 378 $2K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 26 26 $2K
86003 30 26 $2K
87075 181 177 $2K
87530 26 24 $2K
86336 114 110 $2K
87481 106 103 $2K
82150 244 240 $1K
82947 410 404 $1K
84100 323 290 $1K
86147 14 14 $1K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 15 15 $1K
80178 164 152 $1K
86900 387 370 $947.98
82550 178 165 $947.74
86901 358 342 $897.04
82977 130 128 $793.17
82627 41 40 $784.75
86146 14 14 $750.42
82365 92 88 $737.48
86665 24 24 $736.02
99072 74,208 59,233 $610.30
92015 Determination of refractive state 93 92 $590.04
82950 134 123 $561.98
83498 26 26 $547.51
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 17 15 $547.34
83010 42 42 $545.69
84425 28 28 $542.70
87184 97 90 $522.74
82103 42 38 $479.50
86592 139 131 $471.40
82247 88 73 $406.06
87106 39 39 $384.21
85245 15 12 $348.16
84156 116 109 $319.23
86664 24 24 $310.07
86036 30 28 $302.08
86381 12 12 $265.68
85046 57 54 $246.32
85246 14 12 $224.04
85384 25 25 $223.84
82172 14 14 $219.17
83883 13 13 $185.42
83020 20 13 $180.45
84450 37 37 $176.99
86015 15 15 $150.10
85379 13 13 $133.92
85060 13 13 $128.77
82565 27 26 $120.99
80069 13 12 $80.58
85670 12 12 $78.52
85390 12 12 $70.44
86308 13 13 $67.55
86593 13 13 $47.08
81511 502 493 $0.00